Pharma And Health Reform: Staying On The Sidelines Works Out

The failure of the GOP effort to repeal the Affordable Care Act came after a lot of health care stakeholders warned that proposals in the Senate would lead to a disaster. The pharmaceutical industry maintained its silence on the bill – and probably ends up as one of the winners as the dust settles.

Capitol House

More from Pricing Debate

More from Market Access